Skip to main content
. 2022 Aug 1;104-B(8):980–986. doi: 10.1302/0301-620X.104B8.BJJ-2020-1835.R2

Table III.

Frailty outcomes, categorized by Clinical Frailty Scale.

Outcome CFS
1 2 3 4 5 6 7 8 9 p-value
Patients, n 37 112 222 236 227 249 156 14 2
30-day mortality, n (%) 0 (0.0) 2 (1.8) 6 (2.7) 11 (4.7) 19 (8.4) 18 (7.2) 14 (9.0) 1 (7.1) 0 (0.0) < 0.001*
Presence of complications, n (%) 8 (21.6) 27 (24.1) 91 (41.0) 120 (50.8) 112 (49.3) 126 (50.6) 72 (46.2) 6 (42.9) 0 (0.0) < 0.001*
Own home to institution, n (%) 2 (5.6) 9 (8.6) 56 (28.7) 100 (49.3) 99 (57.9) 102 (66.2) 59 (80.8) 3 (75.0) 1 (50.0) 0.427
Own home to own home, n (%) 34 (91.9) 96 (86.5) 139 (64.1) 103 (46.2) 72 (35.1) 52 (28.4) 14 (16.1) 1 (16.7) 1 (50.0)  < 0.001*
Mean length of stay, days (95% CI) 9.03 (7.81 to 10.25) 11.69 (10.67 to 12.72) 15.17 (14.04 to 16.30) 18.11 (16.51 to 19.70) 18.12 (16.40 to 19.85) 18.64 (16.92 to 20.35) 18.28 (15.99 to 20.58) 15.69 (10.08 to 21.30) 9.00 (-3.71 to 21.71) < 0.001
*

Chi-squared test.

Spearman's correlation test.

Analysis of variance with Levene's test for homogeneity and Welch test.

CFS, Clinical Frailty Scale; CI, confidence interval.